In line with our previous findings (Liu et al., 2018; Wang et al., 2021), Gαi1 KO, using the CRISPR/Cas9 method, inhibited Akt activation in P1 glioma cells (Fig. 2G). Here, AKT1 is linked to central nervous system cancer.